Cliff Asness’s ImageneBio Inc IMA Stock Holding History

Cliff Asness’s Portfolio IMA Stock Details IMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,822	Closed	-$36.1K	–	2820
2024 Q2	$36.1K	Buy	+1,822	New	+$32.2K	﹤0.01%	2555

Other funds holding IMA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Acuitas Investments Seattle, Washington $1.43M AUM 17.52% 1-Year Est. Return

Cliff Asness's IMA Position: Q3 2024 in Review

Cliff Asness sold out of ImageneBio Inc (IMA) in Q3 2024, closing a stake of 1,822 shares — an estimated $36.1K sold.

Cliff Asness first reported a position in IMA in Q2 2024 and held it in 1 quarter. The position peaked at $36.1K in Q2 2024. 57 funds tracked by Wall St. Rank hold IMA as of Q3 2024.

Cliff Asness reported no remaining ImageneBio Inc position as of Q3 2024 after selling out during the quarter.
Cliff Asness sold 1,822 ImageneBio Inc shares in Q3 2024, an estimated $36.1K.
Cliff Asness first reported a position in ImageneBio Inc in Q2 2024 and held it in 1 quarter.
Cliff Asness's ImageneBio Inc position peaked at $36.1K in Q2 2024.
57 funds tracked by Wall St. Rank held ImageneBio Inc as of Q3 2024.

Based on AQR Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.